).
| INTRODUCTION
Insulin plays a key role in the regulation of blood glucose levels in response to nutrient state. Insulin is produced by pancreatic β-cells, which must adapt the rate of insulin secretion to myriad physiological conditions. Although insulin demand varies with regard to nutrition, exercise, age and reproductive state, β-cells can compensate for these altered demands with a proportional insulin secretory response. [1] [2] [3] [4] The β-cell's ability to adapt to insulin demand is the key determinant of blood glucose control during metabolic challenges. For example, longitudinal studies of progression to type 2 diabetes mellitus (T2D) indicate that failed compensatory insulin secretion during insulin resistance predicts diabetes susceptibility. 5, 6 Conversely, attenuation of insulin secretion under conditions of fasting or exercise is critical to prevent hypoglycaemia and the ensuing neuroglycopenia. 7 Thus, the adjustment of insulin secretion commensurate with insulin demand is critical for the maintenance of blood glucose control during fluctuations of energy supply.
Insulin secretion is tightly coupled to nutrient state through the sensing of circulating nutrients. 8 Glucose is the key stimulus for insulin secretion, with the rate of its metabolism by the β-cell determining the insulin secretory response ( Figure 1 , and discussed in detail in the next section). β-Cells additionally metabolize fatty acids and amino acids, which modulate insulin secretion during glucose stimulation. 8 Thus, the β-cell serves as a nutrient sensor, with a predominate role for glucose and secondary roles for fatty acids and amino acids.
To accommodate changes of insulin demand, β-cells adjust nutrient metabolism to sensitize or desensitize the insulin secretory response. 1, 9 These adaptations occur through altered activities of metabolic enzymes via several regulatory mechanisms, including allosteric control, covalent modifications, and alterations of protein abundance through transcription and translation. 2, [8] [9] [10] [11] [12] [13] [14] [15] [16] In this way, all relevant inputs from endocrine, neuronal and nutritional sources influence β-cell function according to physiological state.
In this review, we discuss how β-cells metabolically adjust to nutritional challenges and specifically emphasize the role of transcription factors in this process. By controlling expression levels of metabolic enzymes in the β-cell, transcriptional changes establish the context for acute regulation through substrate availability, posttranslational modifications, and allosteric control. Altered expression of metabolic enzymes through transcriptional and subsequent translational changes likely mediates adaptive responses over a time course of hours to days. For example, extended fasting (>24 hours) dampens the insulin secretory response to glucose, and recovery of this response requires transcriptional changes. 13 Furthermore, culturing islets in high glucose enhances insulin secretion during subsequent glucose challenges, and this effect requires ongoing translation. 17, 18 Finally, there is emerging evidence that diurnal rhythms of gene expression in the β-cell influence insulin secretion, 19 indicating that transcriptional changes are relevant to daily adjustments of β-cell function. Thus, modulation of protein abundance through transcription and translation is a key regulatory mechanism for adapting β-cell function to the nutritional state of the organism.
"
By controlling expression levels of metabolic enzymes in the β-cell, transcriptional changes establish the context for acute regulation through substrate availability, post-translational modifications, and allosteric control. Figure 1 ). 8 However, glucose is the only nutrient that is both necessary and sufficient to stimulate insulin secretion. 20 As such, the ratelimiting steps of glycolysis are the key determinants of the initiation of insulin release. The predominant control step of glycolysis in β-cells is glucose phosphorylation, which is catalyzed by the lowaffinity enzyme glucokinase (GK). 8, 20 The kinetics of GK, with a K m of 8 mM, sets the threshold for the rapid acceleration of glucose metabolism responsible for stimulating insulin release. 20 Following completion of glycolysis, glucose enters the tricarboxylic acid (TCA) cycle via pyruvate, thereby increasing cellular ATP. 
| The amplifying pathway of insulin secretion
While the triggering pathway is responsible for initiating insulin secretion in response to a threshold level of glucose, the quantity of insulin released is further adjusted by diverse nutritional signals via the amplifying pathway. 8, 20 The amplifying pathway serves to potentiate the effect of the triggering pathway upon GSIS, and is thus dependent upon concurrent activation of the triggering pathway. 20 The amplifying pathway integrates diverse metabolic cues as well as endocrine and neuronal signals to adjust insulin secretion according to specific physiological states. 8 The dependence upon the triggering pathway ensures that amplification of insulin secretion occurs exclusively in the presence of stimulatory glucose levels. This control step is a safeguard that prevents aberrant stimulation of insulin secretion, which could lead to hypoglycaemia. 23, 24 In this way, metabolic coupling factor production occurs at sites in which nutritional inputs are integrated 8 The convergence of glucose and dietary amino acids at the level of the mitochondria permits the β-cell to sense food intake and mount a proportional insulin secretory response.
The glycerolipid-free fatty acid cycle integrates glucose and fatty acid metabolism to adjust GSIS relative to islet lipid stores, which reflect long-term fuel availability. 24 Within the β-cell, fatty acids can be derived from the circulation or synthesized through de novo lipogenesis ( Figure 1 ). As fatty acids are esterified into glycerolipids, they enter the glycerolipid-free fatty acid cycle. 24 Following glycerolipid synthesis, acyl chains are progressively esterified to form triacylglycerol (via mono-and diacylglycerol). The cycle is completed by subsequent lipolysis, culminating in the release of free fatty acids and glycerol. 24 Enhanced glycerolipid-fatty acid cycling results in the accumulation of signalling lipids, particularly monoacylglycerols, which serve as key metabolic coupling factors. 23 Within islets, the levels of glycerolipid-free fatty acid cycle intermediates fluctuate relative to fuel availability. 24 During fasting, when islet energy stores are low, fatty acids are oxidized to generate ATP, thereby reducing fatty acid availability for the glycerolipid-free fatty acid cycle. 28 In the fed state, de novo lipogenesis increases and fatty acids accumulate. 28 Furthermore, cross-talk between lipid and glucose metabolism links postprandial increases of blood glucose levels to accelerated glycerolipid-free fatty acid cycling. 23, 25 Rapid glucose metabolism leads to the accumulation of cytosolic acetyl-coA and subsequently malonyl-coA, which is a potent inhibitor of fatty acid oxidation. 25 As fatty acids accumulate during glucose stimulation, glycerolipid-free fatty acid cycling is accelerated, resulting in metabolic coupling factor generation and stimulation of the amplifying pathway. 23 Thus, physiological conditions influencing lipid availability and metabolism profoundly influence the insulin secretory response through glycerolipid-free fatty acid cycling.
| β-CELL ADAPTATION TO FASTING
The ability of an organism to store and utilize energy during feeding and fasting requires appropriate insulin signalling at target tissues.
The activity of insulin ensures that glucose is the major energy source in the fed state, while fatty acid utilization dominates in the fasted state. 29 Specifically, insulin serves to promote systemic glucose utilization, to suppress the release of fatty acids from adipose tissue (lipolysis), and to reduce hepatic glucose production in the fed state.
During fasting, the suppression of insulin release is necessary to increase lipolysis by adipocytes, promote hepatic glucose production and reduce glucose disposal by insulin target tissues. 29 These effects are critical for the switch to fatty acid utilization by peripheral tissues during fasting, thereby conserving glucose for use by the brain.
"
Extended fasting is associated with reduced glucose oxidation and accelerated fatty acid oxidation in the β-cell, mediated in part by the lipid-sensing transcription factor Pparα.
In the fasted state, GSIS is attenuated, 30 likely to preserve systemic glucose levels under conditions of sustained nutrient scarcity. 29 The potentiation of GSIS by amino acids is also suppressed during fasting, 31 which may be secondary to reduced activation of the triggering pathway by glucose. However, the stimulatory effect of fatty acids upon insulin secretion is maintained in the fasted state. 32 Thus, the reduced contribution of glucose and amino acids to insulin secretion during fasting results in an expanded role for fatty acids in controlling insulin release. 32 
| Adaptations of glucose metabolism during fasting
The suppression of GSIS during fasting has been attributed in part to reduced glucose metabolism by the β-cell (Figure 2 ). 4 Glucose oxidation is slowed, accompanied by reduced activities of glycolytic enzymes such as GK, hexokinase (HK) and phosphofructokinase (PFK). 10, 33 Rescue experiments with cell-permeable metabolites indicate that decelerated metabolism occurs in upper glycolysis (eg, reactions catalyzed by GK, HK and PFK), supporting a role for these enzymes in the adaptive response to fasting. 4 Finally, activities of GK, HK and PFK recover with the same kinetics as the recovery of GSIS during refeeding. 10 As the phosphorylation steps carried out by these enzymes are key regulatory sites for hormonal and allosteric control of glycolysis, changes in their abundance likely contribute to the control of glucose metabolism during fasting.
| Adaptations of lipid metabolism during fasting
In the fasted state, circulating fatty acid levels are increased, and β-cell fatty acid oxidation is accelerated ( Figure 2 ). 34 Importantly, increased fatty acid catabolism reduces the secretory response to glucose 28 through cross-talk between the metabolism of these nutrients.
As discussed in Section 2, glucose and lipid metabolism converge FIGURE 2 β-Cell metabolism during extended fasting. Glucose metabolism is slowed and fatty acid oxidation is increased, leading to depletion of glycerolipid-free fatty acid (Gly-FFA) cycle-derived coupling factors. Arrow thickness indicates rate of metabolism. ACC, acetyl-coA carboxylase; FAS, fatty acid synthase; FFA, free fatty acid; GK, glucokinase; PC, pyruvate carboxylase; PDH, pyruvate dehydrogenase.
upon the glycerolipid-free fatty acid cycle to gauge metabolic coupling factor generation to levels of lipid stores in the β-cell. Accelerated β-oxidation during fasting depletes glycerolipids, 28, 34 thereby reducing the ability of glucose metabolism to promote metabolic coupling factor generation through this cycle. Pharmacological inhibition of fatty acid oxidation in fasted islets restores glucose responsiveness, 28 emphasizing the importance of accelerated lipid metabolism to β-cell functional adaptations to fasting.
| Transcriptional regulation of β-cell metabolism during fasting
Transcriptional regulation plays a key role in the β-cell response to fasting. The primary role for transcriptional changes in attenuated GSIS during fasting can be demonstrated by pharmacological inhibition of transcription during the refeeding phase. 13 Normally, glucose responsiveness recovers over the course of 1-2 days of refeeding;
however, blocking transcription completely prevents the recovery of GSIS. 13 While transcriptional changes are critical for this response, relatively few genes have been directly implicated. The bestcharacterized transcriptional change associated with reduced GSIS during fasting is the repression of GK, 35, 36 which is known to be rate- 
| Future perspectives of β-cell metabolism during fasting
The ability of the β-cell to attenuate glucose metabolism and insulin secretion in the fasted state is critical for sparing systemic glucose for use by the nervous system. 29 However, several aspects of this adapt- 
| THE ROLE OF METABOLISM IN β-CELL ADAPTATION TO INCREASED WORKLOAD
Nutrient overload is associated with the development of insulin resistance, wherein increased insulin levels are required to reduce blood glucose concentration. To maintain blood glucose homeostasis, the insulin demand must be met by compensatory increases of insulin release by pancreatic β-cells. During adaptation to insulin resistance, the insulin secretory response to glucose is sensitized. 3, 9 In this way, β-cells anticipate postprandial insulin requirements to enable timely normalization of blood glucose levels. Additionally, increased β-cell proliferation expands the functional mass of β-cells, thereby increasing total insulin release, as reviewed elsewhere. 43 Failure of β-cell compensation is the defining event of T2D pathogenesis. 5, 6, 44, 45 Conversely, sustained β-cell adaptation is capable of preventing T2D, even in the face of decades of severe insulin resistance.
"
Compensation for insulin resistance requires accelerated glucose and fatty acid oxidation and increased glycerolipid-free fatty acid cycling, as mediated by transcription factors responsive to insulin (Srebp1c), lipids (Pparα and Pparδ), and cholesterol derivatives (Lxrβ).
Much of what is known about β-cell compensation has been learned from rodent models of increased β-cell workload, which have enabled the study of islet-intrinsic adaptation mechanisms. Universally, these models exhibit increased insulin secretion from β-cells. An increase in β-cell workload can be achieved by either reducing the total number of β-cells or by inducing insulin resistance. The predominant experimental models are the partial pancreatectomized rat 14, 16 as well as several models of obesity. 46 In partial pancreatectomy, a fraction of the pancreas (60%-90%) is removed, thereby causing a requirement for enhanced insulin secretion from the remaining β-cells. 14, 16 Obesity induced by genetic (ob/ob mice, Zucker fatty rats)
or dietary (high-fat diet) manipulations 46 increase β-cell workload due to insulin resistance, and expose the β-cell to additional systemic insults such as dyslipidaemia and inflammation. 
| Glucose metabolism in the β-cell during compensation
One of the defining characteristics of compensating β-cells is a sensitized insulin secretory response to glucose (Figure 3) Increased transcription and activity of GK and low K m HKs has been observed in animal models of β-cell adaptation, 2,14,16 although some variability exists among models. Inhibition of glycolysis reduces basal insulin secretion by compensating islets, 49 indicating that accelerated glucose metabolism indeed drives sensitized GSIS during adaptation to insulin resistance. Several metabolic adaptations relating to the amplifying pathway of GSIS have also been described; eg, pyruvate carboxylase activity is increased and several enzymatic reactions of the pyruvate cycling pathway (malic enzyme, malate dehydrogenase) are accelerated during compensation. 9 This leads to accumulation of mitochondrial metabolites implicated in the production of metabolic coupling factors (Figure 3 ). Treating compensated islets with an inhibitor of pyruvate carboxylase reduces insulin secretion specifically in high glucose, 9 indicating that increased pyruvate carboxylase activity and subsequent activation of the amplifying pathway contribute to enhanced maximal GSIS during adaptation.
| Lipid metabolism during compensation
In obesity, the β-cell must cope with elevated levels of systemic fatty acids and triglycerides. 47 Increased lipid delivery has dual effects on β-cell function, as lipids can stimulate GSIS as well as exert toxic effects upon the β-cell. 50 Thus, increasing insulin secretion during adaptation requires production of lipid-derived metabolic coupling factors while avoiding lipid toxicity.
Lipid toxicity occurs when free fatty acid supply outstrips the capacity for fatty acid oxidation and esterification into triglycerides. 50, 51 Excess free fatty acids can be aberrantly metabolized into signalling molecules that cause β-cell apoptosis. 50 Conversely, esterification into triglycerides diverts fatty acids away from metabolic fates that are toxic to the β-cell. To avoid such toxicity, compensating islets increase fatty acid esterification into triglycerides. 1 Furthermore, increased islet fatty acid oxidation serves to limit lipid accumulation in the obese state ( Figure 3 ). 1 These metabolic adaptations prevent lipid toxicity to preserve β-cell function during obesity. 3 β-Cell metabolism during compensation for increased workload. Both glucose and fatty acid oxidation are accelerated, and metabolic coupling factor production from both the mitochondria and the glycerolipid-free fatty acid (Gly-FFA) cycle is increased. Arrow thickness indicates rate of metabolism. ACC, acetyl-coA carboxylase; FAS, fatty acid synthase; FFA, free fatty acid; GK, glucokinase; PC, pyruvate carboxylase; PDH, pyruvate dehydrogenase.
Excess lipid supply during obesity also contributes to enhanced production of metabolic coupling factors and increased GSIS. 9 Increased triglyceride synthesis in compensating islets provides substrates for glycerolipid-free fatty acid cycling (Figure 3) . 1 Subsequent lipolysis of the resulting triglycerides produces monoacylglycerols, which potentiate GSIS via the amplifying pathway. 23 Accordingly, both triglyceride production and lipolysis are accelerated in compensating islets. 1 Thus, obesity-associated adaptations of lipid metabolism in β-cells permit simultaneous increases of insulin secretion and fatty acid detoxification.
| Transcriptional control of metabolism during β-cell compensation
The adaptation of glucose and lipid metabolism during increased β-cell workload is critical for enhanced GSIS as well as the avoidance of lipid toxicity. An important mechanism of metabolic adaptation is a change in the expression level of genes encoding metabolic enzymes.
The role of transcription factors in β-cell adaptation has been studied using gene knockouts and pharmacological inhibitors. To distinguish between roles of a transcription factor in β-cells and other tissues, ex vivo assays on isolated islets have been used to ascertain β-cellspecific effects. The predominant ex vivo assay for adaptive insulin secretion involves culture of islets for at least 8 hours in high glucose (hereafter referred to as glucose conditioning), 18, 52 which increases GSIS as observed in vivo during insulin resistance. Glucose conditioning mimics the metabolic changes observed in animal models of obesity. 15, 53 Similarly, lipid conditioning, wherein islets are incubated for at least 24 hours in elevated fatty acids, also mimics some of the adaptations found in islets of obese mice such as sensitized GSIS. 48, 54 Ex vivo lipid culture additionally tests the ability of islets to detoxify excess lipids.
The transcription factor sterol regulatory element binding protein 1c (Srebp1c) has been identified as the master regulator of lipogenesis during adaptation to glucose conditioning. In islets, Srebp1c is activated in response to autocrine insulin signalling ( Figure 3 ). In addition to its key function of repressing insulin secretion during fasting, 38 Pparα is also critical for β-cell adaptation to obesity (Figure 3) . 56 Pparα deficiency in ob/ob mice causes β-cell decompensation and hyperglycemia. Interestingly, Ppar-deficient ob/ob mice exhibit normal insulin sensitivity but insufficient insulin secretion, indicating a specific role for Pparα in β-cell adaptation. Thus, Pparα has context-specific functions in the β-cell: the suppression of insulin release during fasting, 38 and appropriate compensation during insulin resistance. 56 Although the exact mechanism of failed compensation in Pparα-deficient mice is unknown, it is possible that the ability of β-cells to detoxify lipids via β-oxidation is perturbed. Supporting such a mechanism, Pparα agonists have been shown to rescue insulin secretion defects of islets challenged ex vivo with high glucose and elevated lipids. (Figure 3 ). 57 Furthermore, Pparδ agonists enhance fatty acid oxidation and improve GSIS in islets of diabetic mice. 58 It has also been proposed that endogenous lipids that normally bind Pparδ are depleted in dysfunctional islets. 
| PERSPECTIVES ON METABOLIC DEFECTS OF DECOMPENSATING β-CELLS
T2D is the end result of insulin demand exceeding the insulin secretory capacity of the β-cell. Longitudinal studies of T2D pathogenesis indicate that insufficient β-cell compensation for insulin resistance is the precipitating event in T2D. 5, 6 The aetiology of β-cell dysfunction and failure in the progression to T2D involves diverse cellular insults and has been reviewed in detail elsewhere. 2, 51 Of note, several metabolic defects contributing to dysfunctional GSIS have been described in islets purified from overtly diabetic donors. Glucose oxidation is slowed and associated with reduced expression of glucose metabolism genes and structural abnormalities of mitochondria ( Figure 4) . 67, 68 Furthermore, metabolic coupling factor generation is reduced in decompensated islets, as described in Section 4 ( Figure 4) . 64, 65 An unresolved question is whether the metabolic abnormalities of β-cells observed in T2D are the cause or effect of poorly controlled hyperglycemia. Although insufficient insulin secretion precipitates the development of T2D, the resulting systemic defects perpetuate β-cell dysfunction. 44, 45, 50, 51 Thus, distinguishing islet abnormalities that are causative of defective GSIS from those that occur secondary to hyperglycemia is challenging, and little is known regarding the metabolic defects of β-cells at the onset of failed compensation. 3 A better understanding of the mechanisms of β-cell adaptation to insulin resistance, and the causes of its failure during T2D progression, would provide insights regarding possible interventions to improve compensation and prevent T2D. 67 Prentki and Madiraju, 24 Weir et al, 2 Supale et al 70 Overview of β-cell metabolism and glucose-stimulated insulin secretion under different physiological and pathological conditions. Arrow thickness indicates rate of metabolism. FA, fatty acid; GSIS, glucose-stimulated insulin secretion; TCA, tricarboxylic acid; T2D, type 2 diabetes mellitus.
glycerolipid-free fatty acid cycling, coordinated by transcription factors responsive to insulin (Srebp1c), lipids (Pparα and Pparδ) and cholesterol derivatives (Lxrβ) (Figure 3 ).
Although we have highlighted several mechanisms of metabolic sensing by the β-cell, much remains to be understood of how the β-cell detects and responds to changes of nutritional state. A few transcription factors that mediate the β-cell response to glucose and lipids have been identified, yet little is known about how responses to other nutrients and metabolites are sensed by β-cells and converted into transcriptional changes. Furthermore, nutrient-responsive transcriptional regulation may extend to the epigenome, through dependence of some chromatin modifying enzymes upon metabolically linked substrates and cofactors. 69 Finally, the discovery of circadian oscillations of gene expression in the islet 19 raises the possibility that nutritional cues could interact with and possibly entrain circadian rhythms in the β-cell. A more comprehensive understanding of β-cell nutrient sensing could improve our understanding of T2D pathogenesis and identify mechanisms to be co-opted for therapeutically modulating insulin secretion in metabolic disease.
